Which of the following is a monoclonal antibody against IL-5
**Core Concept**
The question tests knowledge of **monoclonal antibodies** used in treating diseases by targeting specific **cytokines**, in this case, **Interleukin-5 (IL-5)**. IL-5 is a cytokine involved in the growth and differentiation of **eosinophils**, playing a key role in **asthma** and other **hypereosinophilic disorders**.
**Why the Correct Answer is Right**
The correct answer is a monoclonal antibody that specifically targets IL-5, thereby reducing eosinophilic inflammation. This mechanism is crucial in the management of severe **asthma** and **hypereosinophilic syndrome**. By inhibiting IL-5, the production and survival of eosinophils are decreased, leading to a reduction in inflammation and symptom severity.
**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because it does not target IL-5.
**Option B:** Does not specifically inhibit IL-5.
**Option C:** Is not a monoclonal antibody against IL-5.
**Clinical Pearl / High-Yield Fact**
Monoclonal antibodies against IL-5, such as **Mepolizumab**, are used in the treatment of severe asthma with an eosinophilic phenotype, highlighting the importance of targeted therapy in managing complex diseases.
**Correct Answer:** D. Mepolizumab.